ADORA1
Adenosine receptor A1
Also known as: AA1R_HUMAN, RDC7
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P30542
- Gene
- ADORA1
- Ensembl
- ENSG00000163485
- Chromosome
- 1
- Canonical length
- 326 aa
- Protein class
- FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters
- Subcellular location
- Plasma membrane,Primary cilium
OverviewNCBI Gene
The protein encoded by this gene is an adenosine receptor that belongs to the G-protein coupled receptor 1 family. There are 3 types of adenosine receptors, each with a specific pattern of ligand binding and tissue distribution, and together they regulate a diverse set of physiologic functions. The type A1 receptors inhibit adenylyl cyclase, and play a role in the fertilization process. Animal studies also suggest a role for A1 receptors in kidney function and ethanol intoxication. Transcript variants with alternative splicing in the 5' UTR have been found for this gene. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
326 residues, UniProt reviewed canonical sequence.
>P30542|ADORA1
1 MPPSISAFQA AYIGIEVLIA LVSVPGNVLV IWAVKVNQAL RDATFCFIVS LAVADVAVGA
61 LVIPLAILIN IGPQTYFHTC LMVACPVLIL TQSSILALLA IAVDRYLRVK IPLRYKMVVT
121 PRRAAVAIAG CWILSFVVGL TPMFGWNNLS AVERAWAANG SMGEPVIKCE FEKVISMEYM
181 VYFNFFVWVL PPLLLMVLIY LEVFYLIRKQ LNKKVSASSG DPQKYYGKEL KIAKSLALIL
241 FLFALSWLPL HILNCITLFC PSCHKPSILT YIAIFLTHGN SAMNPIVYAF RIQKFRVTFL
301 KIWNDHFRCQ PAPPIDEDLP EERPDDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ADORA1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 43 nTPM
Expression across tissuesHPA
Tissue
- basal ganglia: 43 nTPM
- spinal cord: 42 nTPM
- midbrain: 41 nTPM
- amygdala: 40 nTPM
- cerebral cortex: 38 nTPM
- hippocampal formation: 37 nTPM
Single-cell type
- podocytes: 139 nCPM
- müller glia: 61 nCPM
- oligodendrocytes: 55 nCPM
- oligodendrocyte progenitor cells: 55 nCPM
- pancreatic duct cells: 31 nCPM
- astrocytes: 30 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- thalamus: 135 nTPM
- pons: 107 nTPM
- white matter: 104 nTPM
- midbrain: 95 nTPM
- basal ganglia: 92 nTPM
- cerebral cortex: 89 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.1
- gnomAD pLI
- 0.02
- gnomAD missense Z
- 2.27
- DepMap mean gene effect
- 0.1
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway
- apoptotic signaling pathway
- cell-cell signaling
- cognition
- detection of temperature stimulus involved in sensory perception of pain
- excitatory postsynaptic potential
- fatty acid homeostasis
- G protein-coupled purinergic nucleotide receptor signaling pathway
- G protein-coupled receptor signaling pathway
- inflammatory response
- leukocyte migration
- lipid catabolic process
- long-term synaptic depression
- mucus secretion
- negative regulation of acute inflammatory response
- negative regulation of apoptotic process
- negative regulation of cell population proliferation
- negative regulation of glutamate secretion
- negative regulation of hormone secretion
- negative regulation of leukocyte migration
- negative regulation of lipid catabolic process
- negative regulation of long-term synaptic depression
- negative regulation of long-term synaptic potentiation
- negative regulation of mucus secretion
- negative regulation of synaptic transmission, GABAergic
- negative regulation of synaptic transmission, glutamatergic
- negative regulation of systemic arterial blood pressure
- nervous system development
- phagocytosis
- positive regulation of dephosphorylation
- positive regulation of lipid catabolic process
- positive regulation of MAPK cascade
- positive regulation of peptide secretion
- positive regulation of potassium ion transport
- positive regulation of systemic arterial blood pressure
- protein targeting to membrane
- regulation of cardiac muscle cell contraction
- regulation of glomerular filtration
- regulation of presynaptic cytosolic calcium ion concentration
- regulation of respiratory gaseous exchange by nervous system process
- regulation of sensory perception of pain
- response to hypoxia
- response to purine-containing compound
- signal transduction
- temperature homeostasis
- triglyceride homeostasis
- vasodilation
- negative regulation of circadian sleep/wake cycle, non-REM sleep
- negative regulation of neurotrophin production
- positive regulation of nucleoside transport
Molecular functions
- G protein-coupled adenosine receptor activity
- G protein-coupled receptor binding
- G-protein beta/gamma-subunit complex binding
- heat shock protein binding
- heterotrimeric G-protein binding
- protein heterodimerization activity
- purine nucleoside binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ADORA1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ADORA1 as an antibody target. Whether an autoantibody or antibody against ADORA1 could matter depends on whether native ADORA1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ADORA1 is annotated at the cell surface, where native ADORA1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label ADORA1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...